Pesquisar
Rallybio Corp
RLYBAdicionar à lista de desejos
16.750USD
-0.110-0.65%
Horário de mercado 09/24, 12:55（ET）
88.78MValor de mercado
PerdaP/L TTM
Sobre o Rallybio Corp Empresa
Rallybio Corporation is a clinical-stage biotechnology company engaged in developing and commercializing life-transforming therapies for patients with severe and rare diseases. It has a pipeline of product candidates aimed at addressing diseases with unmet medical need in the areas of complement dysregulation and hematology. The Company’s lead program, RLYB116, is a differentiated C5 inhibitor with the potential to treat diseases of complement dysregulation, with an initial focus on immune platelet transfusion refractoriness (PTR) and refractory antiphospholipid syndrome (APS). RLYB116 is a novel, once-weekly, small volume, subcutaneously injected C5 inhibitor designed to meet patient demand for a convenient, self-administered at-home solution. Its pipeline also includes RLYB332, a preclinical long-acting matriptase-2 antibody for the treatment of diseases of iron overload. Its RLYB114 is a pegylated C5 inhibitor in development for complement-mediated ophthalmic disorders.
Rallybio Corp Perfil
Código da empresaRLYB
Nome da EmpresaRallybio Corp
Data de listagemJul 29, 2021
CEOUden (Stephen)
Número de funcionários25
Tipo de títulosOrdinary Share
Fim do ano fiscalJul 29
Endereço234 Church Street
CidadeNEW HAVEN
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal06510
Telefone12038593820
Sitehttps://rallybio.com/
Código da empresaRLYB
Data de listagemJul 29, 2021
CEOUden (Stephen)
Executivos da empresa Rallybio Corp
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Ronald M. (Ron) Hunt
Mr. Ronald M. (Ron) Hunt
Independent Director
Independent Director
446.42K
--
Mr. Ronald M. (Ron) Hunt
Mr. Ronald M. (Ron) Hunt
Independent Director
Independent Director
446.42K
--
Mr. Ronald M. (Ron) Hunt
Mr. Ronald M. (Ron) Hunt
Independent Director
Independent Director
446.42K
--
Dr. Stephen (Steve) Uden, M.D.
Dr. Stephen (Steve) Uden, M.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
182.48K
+49.29%
Dr. Stephen (Steve) Uden, M.D.
Dr. Stephen (Steve) Uden, M.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
182.48K
+49.29%
Dr. Stephen (Steve) Uden, M.D.
Dr. Stephen (Steve) Uden, M.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
182.48K
+49.29%
Mr. Jonathan I. (Jon) Lieber
Mr. Jonathan I. (Jon) Lieber
Chief Financial Officer, Treasurer
Chief Financial Officer, Treasurer
48.81K
+91.57%
Mr. Jonathan I. (Jon) Lieber
Mr. Jonathan I. (Jon) Lieber
Chief Financial Officer, Treasurer
Chief Financial Officer, Treasurer
48.81K
+91.57%
Mr. Jonathan I. (Jon) Lieber
Mr. Jonathan I. (Jon) Lieber
Chief Financial Officer, Treasurer
Chief Financial Officer, Treasurer
48.81K
+91.57%
Dr. Hui Liu, Ph.D.
Dr. Hui Liu, Ph.D.
Independent Director
Independent Director
20.96K
--
Ver Mais
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Ronald M. (Ron) Hunt
Mr. Ronald M. (Ron) Hunt
Independent Director
Independent Director
446.42K
--
Mr. Ronald M. (Ron) Hunt
Mr. Ronald M. (Ron) Hunt
Independent Director
Independent Director
446.42K
--
Mr. Ronald M. (Ron) Hunt
Mr. Ronald M. (Ron) Hunt
Independent Director
Independent Director
446.42K
--
Dr. Stephen (Steve) Uden, M.D.
Dr. Stephen (Steve) Uden, M.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
182.48K
+49.29%
Dr. Stephen (Steve) Uden, M.D.
Dr. Stephen (Steve) Uden, M.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
182.48K
+49.29%
Dr. Stephen (Steve) Uden, M.D.
Dr. Stephen (Steve) Uden, M.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
182.48K
+49.29%
Perguntas frequentes
Quem são os cinco principais acionistas de Rallybio Corp?
Os cinco principais acionistas de Rallybio Corp são: Mr. Ronald M. (Ron) Hunt
Quantas instituições possuem ações da Rallybio Corp (RLYB)?
Em 2026Q1, 138 instituições possuíam ações da Rallybio Corp, com valor de mercado aproximado de 3.48M, representando 65.82% do total de ações. Em comparação com 2025Q4, a participação institucional aumentou em -412366.00.